Clinical Significance of sIL-2R Levels in B-Cell Lymphomas

Noriaki Yoshida, Miyo Oda, Yoshiaki Kuroda, +14

PLoS ONE

Lymphocyte DevelopmentIl-2r α ChainImmunologyImmune RegulationPathology +20

Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Takayoshi Kiba, Takuo Ito, Toshihisa Nakashima, +10

BMC Cancer

Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiation

Shoso Munemasa, Akira Sakai, Yoshiaki Kuroda, +6

International Journal of Oncology

Bone RepairImmunomodulatory Thalidomide AnalogsOrthopaedic SurgeryOsteoporosisMyeloid Neoplasia +18

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia

Jun Imagawa, Yuka Harada, Takeshi Shimomura, +5

Blood

A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement

Arisa Okada, Yosuke Harada, Tomoko Inoue, +3

American Journal of Ophthalmology Case Reports

Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not

Shoso Munemasa, Akira Sakai, Yoshiaki Kuroda, +8

British Journal of Haematology

Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells

Yuta Katayama, Akira Sakai, Yoshiko Okikawa, +11

International Journal of Oncology

Hematological MalignancyCell DivisionCyclin D1MedicineMalignant Blood Disorder +13

Unrelated Umbilical Cord Blood Transplantation Using a TBI/FLAG Conditioning Regimen for Adults with Hematologic Malignancies

Masaya Okada, Yoshihiro Fujimori, Mahito Misawa, +12

Biology of Blood and Marrow Transplantation

Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab

Yoshiyasu Kono, Yasuhiro Choda, Masahiro Nakagawa, +11

Targeted Oncology

Gastrointestinal OncologyMedicineImmunologyGastroenterologyImmune Checkpoint Inhibitor +5

Good's Syndrome-Associated Pure Red Cell Aplasia with Myelodysplastic Syndrome

Hideaki Nitta, Yuka Harada, Yoshiko Okikawa, +4

Internal Medicine

Down SyndromeMyelodysplastic SyndromeAutoimmune DiseaseMds-complicated CaseBone Marrow Failure +13